$7.04
+0 (+0%)
At Close: Nov 14, 2025
Captivating Stock: 180 Life Sciences Corp. (NASDAQ:ATNF), Xinyuan Real Estate Co., Ltd. (NYSE:XIN)
08:50am, Monday, 06'th Dec 2021 Stock Equity
180 Life Sciences Corp. (ATNF) with the stream of -15.28% also noticed, India Xinyuan Real Estate Co., Ltd. (XIN) encountered a rapid change of -2.74% in the last hour of The post Captivating Stock: 180 Life Sciences Corp. (NASDAQ:ATNF), Xinyuan Real Estate Co., Ltd. (NYSE:XIN) appeared first on Stocks Equity .
180 Life Sciences falls 25% following data on Humira for Dupuytren contracture
06:28pm, Thursday, 02'nd Dec 2021 Seeking AlphaBiofrontera, Terns Pharmaceuticals leads healthcare gainers; Context Therapeutics, 180 Life Sciences among major losers
04:03pm, Thursday, 02'nd Dec 2021 Seeking Alpha180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial
07:45pm, Wednesday, 01'st Dec 2021 GlobeNewswire Inc.
‘Cellular and Molecular Profiling of Dupuytren’s Disease: From the Lab to the Clinic’ Presented Wednesday, December 1, 2021, at 3pm EST ‘Cellular and Molecular Profiling of Dupuytren’s Disea
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
01:36pm, Wednesday, 01'st Dec 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir
The Food and Drug Adminis
BTFDers Unleashed: Futures, Yields, Oil Jump As Omicron Panic Eases
01:01pm, Monday, 29'th Nov 2021 Zero Hedge
BTFDers Unleashed: Futures, Yields, Oil Jump As Omicron Panic Eases As expected over the weekend, and as we first noted shortly after electronic markets reopened for trading on Sunday, S&P futures have maintained their overnight gains and have rebounded 0.7% while Nasdaq contracts jumped as much as 1.3% after risk sentiment stabilized following Fridays carnage and as investors settled in for a few weeks of uncertainty on whether the Omicron variant would derail economic recoveries and the tightening plans of some central banks. Japan led declines in the Asian equity session (which was catching down to Friday''s US losses) after the government shut borders to visitors. The regions reopening stocks such as restaurants, department stores, train operators and travel shares also suffered some losses. Oil prices bounced $3 a barrel to recoup some of Friday''s rout, while the safe haven yen, Swiss franc and 10Y Treasury took a breather after its run higher. Moderna shares jumped as much as 12% in pre-market trading after Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year.
Hooky Stock: 180 Life Sciences Corp. (NASDAQ:ATNF), SuperCom Ltd. (NASDAQ:SPCB)
03:41am, Monday, 29'th Nov 2021 Stock Equity
180 Life Sciences Corp. (ATNF) with the stream of 21.30% also noticed, India SuperCom Ltd. (SPCB) encountered a rapid change of 2.94% in the last hour of trading session. 180 The post Hooky Stock: 180 Life Sciences Corp. (NASDAQ:ATNF), SuperCom Ltd. (NASDAQ:SPCB) appeared first on Stocks Equity .
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
02:43pm, Sunday, 28'th Nov 2021 Benzinga
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-s
180 Life Sciences Corp Shares Close the Day 21.3% Higher - Daily Wrap
01:03am, Sunday, 28'th Nov 2021 Kwhen Finance
180 Life Sciences Corp (ATNF) shares closed today 21.3% higher than it did at the end of yesterday. The stock is currently up 98.2% year-to-date, up 94.6% over the past 12 months, and down 44.2% over the past five years. Today, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 2.2%. Trading Activity Shares traded as high as $5.58 and as low as $3.89 this week.Shares closed 58.5% below its 52-week high and 148.2% above its 52-week low.Trading volume this week was 49.7% lower than the 10-day average and 16.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 3.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -411.7% The company's stock price performance over the past 12 months beats the peer average by -472.0%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
180 Life Sciences Corp Shares Close the Week 33.6% Higher - Weekly Wrap
01:03am, Sunday, 28'th Nov 2021 Kwhen Finance
180 Life Sciences Corp (ATNF) shares closed this week 33.6% higher than it did at the end of last week. The stock is currently up 98.2% year-to-date, up 94.6% over the past 12 months, and down 44.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Shares traded as high as $5.58 and as low as $3.89 this week.Shares closed 58.5% below its 52-week high and 148.2% above its 52-week low.Trading volume this week was 49.7% lower than the 10-day average and 16.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 3.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -411.7% The company's stock price performance over the past 12 months beats the peer average by -472.0%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
180 Life Sciences Corp. (NASDAQ: ATNF): Up 56.20% In 2021, Outlook Remains Positive
04:30pm, Tuesday, 23'rd Nov 2021 Stocks Register
The trading price of 180 Life Sciences Corp. (NASDAQ:ATNF) closed lower on Monday, November 22, closing at $4.03, -0.49% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy
180 Life Sciences Corp. Expands Patent Portfolio
01:30pm, Monday, 22'nd Nov 2021 GlobeNewswire Inc.
New IP Relates to a Method for Treating Chronic Pain or Associated Conditions/Symptoms with Novel Compositions Including Certain Phenyl Substituted Cyclohexenyl Compounds Related to Cannabidiol (CBD)
180 Life Sciences Corp. Expands Patent Portfolio
01:30pm, Monday, 22'nd Nov 2021 Intrado Digital Media
New IP Relates to a Method for Treating Chronic Pain or Associated Conditions/Symptoms with Novel Compositions Including Certain Phenyl Substituted Cyclohexenyl Compounds Related to Cannabidiol (CBD) New IP Relates to a Method for Treating Chronic Pain or Associated Conditions/Symptoms with Novel Compositions Including Certain Phenyl Substituted Cyclohexenyl Compounds Related to Cannabidiol (CBD)
180 Life Sciences (ATNF) Stock: Why The Price Jumped Today
03:33pm, Thursday, 18'th Nov 2021
The stock price of 180 Life Sciences Corp (NASDAQ: ATNF) increased by over 7% during intraday trading today. This is why it happened.
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium
01:15pm, Thursday, 18'th Nov 2021 GlobeNewswire Inc.
‘Re-purposing anti-TNF for Dupuytren’s Disease’ Being Presented Wednesday, December 1, 2021, at 3pm EST ‘Re-purposing anti-TNF for Dupuytren’s Disease’ Being Presented Wednesday, December
Sign In
Buy ATNF